CrossAmerica Partners LP has a consensus price target of $15, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Wells Fargo on December 16, 2021. With an average price target of $15 between Wells Fargo, there's an implied -33.57% downside for CrossAmerica Partners LP from these 1 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
12/16/2021 | CAPL | Buy Now | CrossAmerica Partners | $22.58 | -33.57% | Wells Fargo | Ned Baramov | — | Maintains | Underweight | Get Alert |
The latest price target for CrossAmerica Partners (NYSE: CAPL) was reported by Wells Fargo on December 16, 2021. The analyst firm set a price target for $15.00 expecting CAPL to fall to within 12 months (a possible -33.57% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for CrossAmerica Partners (NYSE: CAPL) was provided by Wells Fargo, and CrossAmerica Partners maintained their underweight rating.
There is no last upgrade for CrossAmerica Partners.
There is no last downgrade for CrossAmerica Partners.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CrossAmerica Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CrossAmerica Partners was filed on December 16, 2021 so you should expect the next rating to be made available sometime around December 16, 2022.
While ratings are subjective and will change, the latest CrossAmerica Partners (CAPL) rating was a maintained with a price target of $16.00 to $15.00. The current price CrossAmerica Partners (CAPL) is trading at is $22.58, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.